Literature DB >> 3733311

Muscle soreness and serum creatine kinase activity following isometric, eccentric, and concentric exercise.

P M Clarkson, W C Byrnes, K M McCormick, L P Turcotte, J S White.   

Abstract

Serum creatine kinase (CK) activity and subjective ratings of muscle soreness were assessed in 28 college women following three different arm flexion exercise regimens. The subjects were randomly assigned to an eccentric, isometric, or concentric exercise regimen. Each regimen was equated for total work time and work-to-rest ratio. Blood samples for determination of serum CK activity and perceived soreness ratings were obtained prior to and 5, 10, and 25 h following each exercise. Significant increases in perceived soreness ratings were observed for each exercise regimen. The magnitude of the post-exercise increase in perceived soreness was greatest for the eccentric and the isometric exercises with minimal soreness following the concentric exercise. A small but significant increase in serum CK activity was observed following the three exercises (eccentric = 35.8%, concentric = 37.6%, isometric = 34.0%). The post-exercise serum CK increases did not differ significantly among the three regimens. The rise in serum CK activity suggests that muscle damage occurred during all three tasks. However, due to multiple factors which can affect serum CK levels, the increase in serum CK activity may not provide a sensitive indicator of the magnitude of the injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733311     DOI: 10.1055/s-2008-1025753

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  41 in total

Review 1.  Delayed onset muscle soreness : treatment strategies and performance factors.

Authors:  Karoline Cheung; Patria Hume; Linda Maxwell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Muscle fiber conduction velocity is more affected after eccentric than concentric exercise.

Authors:  Harri Piitulainen; Alberto Botter; Roberto Merletti; Janne Avela
Journal:  Eur J Appl Physiol       Date:  2010-09-24       Impact factor: 3.078

Review 3.  Exercise-induced muscle damage and adaptation.

Authors:  C B Ebbeling; P M Clarkson
Journal:  Sports Med       Date:  1989-04       Impact factor: 11.136

4.  Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers.

Authors:  George A Milias; Tzortzis Nomikos; Elizabeth Fragopoulou; Spyridon Athanasopoulos; Smaragdi Antonopoulou
Journal:  Eur J Appl Physiol       Date:  2005-09-06       Impact factor: 3.078

5.  Release of alpha-actin into serum after skeletal muscle damage.

Authors:  A Martínez-Amat; H Boulaiz; J Prados; J A Marchal; P Padial Puche; O Caba; F Rodríguez-Serrano; A Aránega
Journal:  Br J Sports Med       Date:  2005-11       Impact factor: 13.800

6.  Changes in fluctuation of isometric force following eccentric and concentric exercise of the elbow flexors.

Authors:  Andrew P Lavender; Kazunori Nosaka
Journal:  Eur J Appl Physiol       Date:  2005-10-26       Impact factor: 3.078

7.  The shift in muscle's length-tension relation after exercise attributed to increased series compliance.

Authors:  J E Gregory; D L Morgan; T J Allen; U Proske
Journal:  Eur J Appl Physiol       Date:  2006-12-22       Impact factor: 3.078

8.  Pathophysiology of acute exercise-induced muscular injury: clinical implications.

Authors:  P Page
Journal:  J Athl Train       Date:  1995-03       Impact factor: 2.860

Review 9.  The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development.

Authors:  Brad J Schoenfeld
Journal:  Sports Med       Date:  2012-12-01       Impact factor: 11.136

10.  Massage therapy restores peripheral vascular function after exertion.

Authors:  Nina C Franklin; Mohamed M Ali; Austin T Robinson; Edita Norkeviciute; Shane A Phillips
Journal:  Arch Phys Med Rehabil       Date:  2014-02-25       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.